心内膜下与透壁性心肌缺血:临床特征、患病率及血运重建与否的结局
本研究基于6331例负荷PET(铷-82)前瞻性10年随访,定义心内膜下与透壁性灌注缺损的大小和严重程度及其临床关联与结局。严重冠脉血流容量(CFC)降低者占20.7%,其10年主要不良心脏事件发生率为44.4%,显著高于无严重CFC异常者的8.8%。无严重CFC异常但负荷诱发心绞痛或ST段压低者,82%存在心内膜下灌注异常,但事件风险低。
要点
- 负荷PET可定量心内膜下灌注,无区域透壁灌注缺损的心内膜下低灌注常见且多无症状。
- 严重CFC降低者心绞痛或ST段压低比例不足一半,但10年MACE风险高,血运重建后死亡率降低。
- 无严重CFC异常时,心内膜下灌注异常提示无症状非阻塞性弥漫冠心病或非狭窄性心绞痛。
关键影像表现/征象
- 严重CFC降低者占20.7%(1316/6331),其中41.4%在充血应激期间出现心绞痛或ST段压低>1 mm,比例随缺损大小增加。
- 无严重CFC异常的5015例中,402例(8%)在负荷期间出现心绞痛或ST段压低,其中82%存在心内膜下灌注异常,8.7%出现心绞痛或ST段压低>1 mm。
- 947例负荷诱发心绞痛或ST段压低>1 mm者中,945例(99.8%)存在透壁或心内膜下灌注降低,仅2例(0.2%)心内膜下灌注正常。
诊断标准与关键数值
- 严重CFC降低者10年MACE发生率为44.4%,无严重CFC者为8.8%(未校正P < 0.00001)。
- 严重CFC降低者死亡率:未血运重建15.2%,血运重建6.9%(P < 0.00002),多变量Cox回归确认。
- 无严重CFC者死亡率:血运重建与否均为3%(P = 0.90)。
临床应用与阅片要点
- 阅片时应关注心内膜下灌注参数(如应力心内膜下/心外膜下比值),即使无区域透壁灌注缺损也可能提示心内膜下缺血。
- 无严重CFC异常且无负荷诱发症状时,心内膜下低灌注可能为良性表现,报告需结合症状与CFC综合判断。
- 严重CFC降低者心绞痛症状可能缺如,但死亡风险高,应提示临床评估血运重建获益。
局限性
- 研究为单中心设计,结果外推需谨慎。
- 随访期间平均5年,部分患者可能失访或治疗交叉影响结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Subendocardial ischemia is commonly diagnosed but not quantified by imaging.
OBJECTIVES: This study sought to define size and severity of subendocardial and transmural stress perfusion deficits, clinical associations, and outcomes.
METHODS: Regional rest-stress perfusion in mL/min/g, coronary flow reserve, coronary flow capacity (CFC), relative stress flow, subendocardial stress-to-rest ratio and stress subendocardial-to-subepicardial ratio as percentage of left ventricle were measured by positron emission tomography (PET) with rubidium Rb 82 and dipyridamole stress in serial 6,331 diagnostic PETs with prospective 10-year follow-up for major adverse cardiac events with and without revascularization.
RESULTS: Of 6,331 diagnostic PETs, 1,316 (20.7%) had severely reduced CFC with 41.4% having angina or ST-segment depression (STΔ) >1 mm during hyperemic stress, increasing with size. For 5,015 PETs with no severe CFC abnormality, 402 (8%) had angina or STΔ during stress, and 82% had abnormal subendocardial perfusion with 8.7% having angina or STΔ >1 mm during dipyridamole stress. Of 947 cases with stress-induced angina or STΔ >1 mm, 945 (99.8%) had reduced transmural or subendocardial perfusion reflecting sufficient microvascular function to increase coronary blood flow and reduce intracoronary pressure, causing reduced subendocardial perfusion; only 2 (0.2%) had normal subendocardial perfusion, suggesting microvascular disease as the cause of the angina. Over 10-year follow-up (mean 5 years), severely reduced CFC associated with major adverse cardiac events of 44.4% compared to 8.8% for no severe CFC (unadjusted P < 0.00001) and mortality of 15.2% without and 6.9% with revascularization (P < 0.00002) confirmed by multivariable Cox regression modeling. For no severe CFC, mortality was 3% with and without revascularization (P = 0.90).
CONCLUSIONS: Reduced subendocardial perfusion on dipyridamole PET without regional stress perfusion defects is common without angina, has low risk of major adverse cardiac events, reflecting asymptomatic nonobstructive diffuse coronary artery disease, or angina without stenosis. Severely reduced CFC causes angina in fewer than one-half of cases but incurs high mortality risk that is significantly reduced after revascularization.
引用
- Gould, Nguyen, Kirkeeide, et al. Subendocardial and Transmural Myocardial Ischemia: Clinical Characteristics, Prevalence, and Outcomes With and Without Revascularization. JACC Cardiovasc Imaging. 2022. PMID: 36599572. doi:10.1016/j.jcmg.2022.05.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。